Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients-Reference-Cited by-同舟云学术

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients

Published:2022-06-07 Issue:8 Volume:29 Page:2420-2430
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Magen Iddo¹²^ORCID,Aharoni Sharon³⁴^ORCID,Yacovzada Nancy Sarah¹²,Tokatly Latzer Itay⁴⁵,Alves Christiano R. R.⁶,Sagi Liora⁴⁵,Fattal‐Valevski Aviva⁴⁵,Swoboda Kathryn J.⁶,Katz Jacob⁴⁷,Bruckheimer Elchanan⁴⁸,Nevo Yoram³⁴^ORCID,Hornstein Eran¹²^ORCID

Affiliation:

1. Department of Molecular Genetics Weizmann Institute of Science Rehovot Israel

2. Department of Molecular Neuroscience Weizmann Institute of Science Rehovot Israel

3. Institute of Pediatric Neurology Schneider Children's Medical Center of Israel Petach Tikva Israel

4. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

5. Pediatric Neurology Institute Dana‐Dwek Children's Hospital Tel Aviv Medical Center Tel Aviv Israel

6. Department of Neurology Center for Genomic Medicine Massachusetts General Hospital Boston Massachusetts USA

7. Division of Department of Anesthesia Schneider Children's Medical Center of Israel Petach Tikva Israel

8. Cardiology Institute Schneider Children's Medical Center of Israel Petach Tikva Israel

Funder

FP7 Ideas: European Research Council

Teva Pharmaceutical Industries

Amyotrophic Lateral Sclerosis Association

Fondation Thierry Latran

E-Rare

Target ALS

National Institute of Neurological Disorders and Stroke

National Institute of Child Health and Human Development

Biogen

Israel Science Foundation

Legacy Heritage Fund

Cure SMA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15382

Reference51 articles.

1. Spinal Muscular Atrophy Genetic Testing Experience at an Academic Medical Center

2. Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review

3. Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy

4. SMN gene deletions in adult-onset spinal muscular atrophy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase Ib/IIa study of Enoxacin in patients with ALS;2024-08-01

2. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

3. Spinal muscular atrophy 5q. Clinical and genetic characteristics, molecular genetic diagnosis and etiopathogenetic treatment. 2nd ed.;2024-04-18

4. 270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands;Neuromuscular Disorders;2024-01

5. Spinal Muscular Atrophy Types, Innovations in Diagnosis and Treatment;Journal of Dr Behcet Uz Children s Hospital;2023-12-04